Cara Therapeutics Inc

BNP PARIBAS FINANCIAL MARKETS

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/13/2024

Shares

582,536

Value ($000)

179

Weight

0.0%

2019 Q4 - 2024 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/13/2024	179	0.0%	582,536	9/30/2024
2024 Q2	8/13/2024	278	0.0%	1,076,807	6/30/2024
2024 Q1	5/1/2024	260	0.0%	286,205	3/31/2024
2023 Q4	2/14/2024	218	0.0%	292,854	12/31/2023
2023 Q3	11/14/2023	113	0.0%	67,021	9/30/2023
2023 Q2	8/9/2023	220	0.0%	77,618	6/30/2023
2023 Q1	5/12/2023	307	0.0%	62,538	3/31/2023
2022 Q4	2/14/2023	141	0.0%	13,109	12/31/2022
2022 Q3	11/16/2022	330	0.0%	35,218	9/30/2022
2022 Q2	8/12/2022	208	0.0%	22,760	6/30/2022
2022 Q1	5/18/2022	403	0.0%	33,132	3/31/2022
2021 Q4	2/9/2022	442	0.0%	36,320	12/31/2021
2021 Q3	11/16/2021	858	0.0%	55,509	9/30/2021
2021 Q2	8/10/2021	450	0.0%	31,504	6/30/2021
2021 Q1	5/7/2021	355	0.0%	16,364	3/31/2021
2020 Q4	2/10/2021	196	0.0%	12,927	12/31/2020
2020 Q3	10/30/2020	122	0.0%	9,567	9/30/2020
2020 Q2	8/6/2020	25	0.0%	1,476	6/30/2020
2020 Q1	5/13/2020	164	0.0%	12,379	3/31/2020
2019 Q4	2/12/2020	76	0.0%	4,712	12/31/2019